Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

JCO precision oncology·2026
Same author

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Nature communications·2026
Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026
Same author

Paediatric therapeutic development workshop on medulloblastoma.

British journal of cancer·2026
Same author

Reply to: Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

A Toddler With Iron Deficiency Anemia Secondary to a Yolk Sac Tumor of the Stomach: A Case Report and Literature Review.

Case reports in pediatrics·2026

Related Experiment Video

Updated: May 22, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.

Maria Isabel Achatz1, Anita Villani2, Alison A Bertuch3

  • 1Centro de Oncologia, Hospital Sírio-Libanês, Sao Paulo, Brazil.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|March 12, 2025
PubMed
Summary

Li-Fraumeni syndrome (LFS) surveillance guidelines are updated to reflect evolving knowledge of TP53 variants. Recommendations now include age-dependent screening and address adult carrier surveillance, improving early cancer detection and outcomes.

More Related Videos

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.8K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K

Related Experiment Videos

Last Updated: May 22, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.8K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K

Area of Science:

  • Genetics
  • Oncology
  • Cancer Predisposition Syndromes

Background:

  • Li-Fraumeni syndrome (LFS) is an inherited condition with a high risk of various cancers due to TP53 gene mutations.
  • Secondary cancers and treatment-related morbidity are significant concerns in LFS patients.

Purpose of the Study:

  • To provide an updated clinical overview of LFS.
  • To present revised consensus tumor surveillance recommendations from the 2023 AACR Childhood Cancer Predisposition Workshop.

Main Methods:

  • Review and synthesis of current understanding of LFS genotype-phenotype relationships.
  • Adaptation of existing surveillance protocols, including the Toronto Protocol.
  • Consideration of age-dependent screening modalities and transition of care for adult carriers.

Main Results:

  • Evolved understanding of LFS necessitates modifications to surveillance strategies.
  • Updated recommendations emphasize age-dependent screening and detailed surveillance for adult TP53 variant carriers.
  • The revised guidelines aim to optimize early cancer detection and reduce mortality and morbidity.

Conclusions:

  • Lifelong surveillance remains crucial for Li-Fraumeni syndrome.
  • Age-specific screening and tailored adult surveillance are essential for improved management.
  • Continued research and guideline updates are vital for managing TP53-related cancer predisposition.